Alpha-1 Antitrypsin Deficiency Support from Alpha 1 Awareness UK


Welcome to Alpha-1 Awareness UK

Alpha-1 Antitrypsin Deficiency

Alpha-1 antitrypsin deficiency is a genetic defect on chromosome 14 that causes the liver either not to produce the protein alpha-1 antitrypsin (AAT) or to produce this substance with errors in the structure of its molecules. These badly formed molecules fold incorrectly and are largely unable to leave the liver.

In contrast to the rest of the body, the problem in the liver is not a lack of but rather an accumulation of abnormally folded protein in the liver cells, and this damages them. In turn, the damaged cells can lead to prolonged jaundice in the new-born or bile stasis or chronic liver disease in children. Affected children often have poor appetite and fail to thrive. Although 10 to 20% of children with alpha-1 antitrypsin deficiency have liver involvement, that figure drops to 2 to 5% with increasing age. However, there are Alpha-1 patients who do not develop any symptoms until adult age. They are then more likely to develop cirrhosis (scarring) or cancer of the liver. As yet there is no specific drug treatment for liver alphas.

Alpha-1 Children

Some children with alpha-1 antitrypsin deficiency have damaged livers. The treatment for this condition is highly specialised and there are excellent liver treatment centres for these children. If you have any concerns about your child then seek medical advice.

Sometimes Alpha children have breathing difficulties but these are usually related to other lung diseases and treatments are also available for these. (Replacement therapy is not indicated for these children’s lung complaints.)

This website is run by Alphas and their carers. We do our very best to ensure that all information shown here is up-to-date and accurate. However, you should always consult your own GP or other medical professional if you have the slightest concerns about your health.

Donate with JustGiving

FIND-A1

The FIND-A1 project is designed to engage patients, doctors, nurses and other medical healthcare providers in the detection of the many alpha-1 antitrypsin deficient (A1AT/AATD) patients who are currently not diagnosed, or who are diagnosed as having some other condition.


Latest News

Pulmonary Rehabilitation

The European Lung Foundation (ELF) is conducting a new survey into patients experience of pulmonary
Read More

Alpha-1 Global Website

Alpha-1 Global has launched its website www.alpha-1global.org. The intention is that the website wil
Read More

ERS Presidential Award

This year the European Respiratory Society Presidential Award is going to Professor Rob Stockley. Pr
Read More

Looking After Your Liver

Birmingham University and FutureLearn have created a free online course where you can learn about ho
Read More